News
Not so NICE: cancer patients miss out on innovative new treatments
Institute for Cancer Research highlights missed opportunity for NICE to reform its cancer drug assessment processes
You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.
Institute for Cancer Research highlights missed opportunity for NICE to reform its cancer drug assessment processes